You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 11, 2025

Solriamfetol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for solriamfetol
Recent Clinical Trials for solriamfetol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 2
National Multiple Sclerosis SocietyPhase 2
Axsome Therapeutics, Inc.Phase 2

See all solriamfetol clinical trials

Generic filers with tentative approvals for SOLRIAMFETOL
Applicant Application No. Strength Dosage Form
⤷  Try for Free⤷  Try for Free75MGTABLET
⤷  Try for Free⤷  Try for Free300MGTABLET
⤷  Try for Free⤷  Try for Free150MGTABLET

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for solriamfetol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes 8,877,806 ⤷  Try for Free ⤷  Try for Free
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes 12,090,126 ⤷  Try for Free ⤷  Try for Free
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes 11,753,368 ⤷  Try for Free ⤷  Try for Free
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes 12,036,194 ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.